X4 Pharmaceuticals (XFOR) Reports In-Line Q2 EPS
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of ($0.74), in-line with the analyst estimate of ($0.74).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of ($0.74), in-line with the analyst estimate of ($0.74).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.